Noteworthy Monday Option Activity: NVDA, AAPL, COIN
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in NVIDIA Corp (Symbol: NVDA), where a total of 2.1 million contracts have traded so far, representing approximately 207.2 million underlying shares. That amounts to about 177.8% of NVDA's average daily trading volume over the past month of 116.6 million shares. Especially high volume was seen for the $212.50 strike call option expiring August 24, 2026, with 227,324 contracts trading so far today, representing approximately 22.7 million underlying shares of NVDA. Below is a chart showing NVDA's trailing twelve month trading history, with the $212.50 strike highlighted in orange:
Apple Inc (Symbol: AAPL) saw options trading volume of 736,907 contracts, representing approximately 73.7 million underlying shares or approximately 139% of AAPL's average daily trading volume over the past month, of 53.0 million shares. Particularly high volume was seen for the $315 strike call option expiring August 24, 2026, with 154,702 contracts trading so far today, representing approximately 15.5 million underlying shares of AAPL. Below is a chart showing AAPL's trailing twelve month trading history, with the $315 strike highlighted in orange:
And Coinbase Global Inc (Symbol: COIN) saw options trading volume of 88,304 contracts, representing approximately 8.8 million underlying shares or approximately 93.8% of COIN's average daily trading volume over the past month, of 9.4 million shares. Especially high volume was seen for the $200 strike call option expiring August 28, 2026, with 12,912 contracts trading so far today, representing approximately 1.3 million underlying shares of COIN. Below is a chart showing COIN's trailing twelve month trading history, with the $200 strike highlighted in orange:
For the various different available expirations for NVDA options, AAPL options, or COIN options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Further NVDA Research:
